Lung adenocarcinoma Antibody
Lung adenocarcinoma Antibody
Human Lung Adenocarcinoma CAFs |
|||
CAF117 | Neuromics | each | 1294.92 EUR |
Lung adenocarcinoma tissue array |
|||
LC10014a | TissueArray | each | 414 EUR |
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM, clinical stage and IHC of TTF-1 results, 50 cases/100 cores, replacing LC10014 |
|||
Lung adenocarcinoma tissue array |
|||
LC641 | TissueArray | each | 198 EUR |
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM/Stage, 64 cases/ 64 cores |
|||
Lung adenocarcinoma tissue array |
|||
LC706a | TissueArray | each | 306 EUR |
Description: Lung adenocarcinoma tissue array, including TNM, clinical stage and pathology grade, 75 cases/75 cores, replaced by LC706a |
|||
Lung adenocarcinoma tissue array |
|||
LC706b | TissueArray | each | 306 EUR |
Description: Lung adenocarcinoma tissue array, including pathology grade, TNM and clinical stage, 75 cases/75 cores, replacing LC706a |
|||
Lung adenocarcinoma with lung tissue array |
|||
LC402 | TissueArray | each | 270 EUR |
Description: Lung adenocarcinoma with lung tissue array, including pathology grade, TNM and clinical stage (AJCC 8.0), 30 cases/40 cores (core size 1.5mm) |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238) Antibody |
|||
BNUB1238-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238), 1mg/mL |
|||
Lung Tissue Slide (Adenocarcinoma) |
|||
10-106-10um | ProSci | 10 um | 241.8 EUR |
Lung Tissue Slide (Adenocarcinoma) |
|||
10-106-4um | ProSci | 4 um | 216.6 EUR |
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNUB1880-50 | Biotium | 50uL | 486 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), 1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC701880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC701880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC801880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC801880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC811880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC811880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC551880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC551880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC611880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC611880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC431880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC431880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC051880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNC051880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCA1880-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), APC conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCAP1880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCAP1880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCH1880-100 | Biotium | 100uL | 279.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCH1880-500 | Biotium | 500uL | 654 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCP1880-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239) Antibody |
|||
BNCR1880-250 | Biotium | 250uL | 472.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) (rNAPSA/1239), RPE conjugate, Concentration: 0.1mg/mL |
|||
Immortalized Human Lung Adenocarcinoma CAFs |
|||
CAF117-IM | Neuromics | each | 7018.92 EUR |
Anti-Napsin A (Lung Adenocarcinoma Marker) Monoclonal Antibody |
|||
M05685-1 | BosterBio | 100ug/vial | 476.4 EUR |
Description: Mouse Monoclonal Napsin A (Lung Adenocarcinoma Marker) Antibody. Validated in IHC and tested in Human. |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCAP1254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCAP1254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCH1254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCH1254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC701254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC701254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC801254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC801254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC811254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC811254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC551254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC551254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC431254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC431254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC611254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC611254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC051254-100 | Biotium | 100uL | 238.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNC051254-500 | Biotium | 500uL | 652.8 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCA1254-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), APC conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCP1254-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Napsin A (Lung Adenocarcinoma Marker) (NAPSA/1238 + NAPSA/1239) Antibody |
|||
BNCR1254-250 | Biotium | 250uL | 459.6 EUR |
Description: Primary antibody against Napsin A (Lung Adenocarcinoma Marker) ( NAPSA/1238 + NAPSA/1239), RPE conjugate, Concentration: 0.1mg/mL |
|||
Human Lung Slide (Adenocarcinoma) (5 slides/pk) |
|||
HTS-10106 | Alpha Diagnostics | 1 pk | 343.2 EUR |
Monoclonal Napsin A (Lung Adenocarcinoma Marker) Antibody, Clone: NAPSA/1238 |
|||
AMM01560G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human Napsin A (Lung Adenocarcinoma Marker). The antibodies are raised in Mouse and are from clone NAPSA/1238. This antibody is applicable in WB, IHC and IF, FC |
|||
Monoclonal Napsin A (Lung Adenocarcinoma Marker) Antibody, Clone: NAPSA/1239 |
|||
AMM01563G | Leading Biology | 7 ml | 580.8 EUR |
Description: A Monoclonal antibody against Human Napsin A (Lung Adenocarcinoma Marker). The antibodies are raised in Mouse and are from clone NAPSA/1239. This antibody is applicable in WB, IHC and IF, FC |
|||
Lung adenocarcinoma with matched adjacent normal lung tissue array |
|||
LC10013c | TissueArray | each | 306 EUR |
Description: Lung adenocarcinoma with matched adjacent normal lung tissue array, including pathology grade, TNM and clinical stage, 52 cases/100 cores, replacing LC10013b |
|||
GFP-Human Lung [SCLC] Adenocarcinoma Cells (H69) |
|||
cAP-0103GFP | Angio Proteomie | 1Frozen Vial | 782.1 EUR |
RFP-Human Lung [SCLC] Adenocarcinoma Cells (H69) |
|||
cAP-0103RFP | Angio Proteomie | 1Frozen Vial | 782.1 EUR |
GFP-Human Lung [SCLC] Adenocarcinoma Cells (H82) |
|||
cAP-0104GFP | Angio Proteomie | 1Frozen Vial | 782.1 EUR |
GFP-Human Lung [SCLC] Adenocarcinoma Cells (H69) |
|||
ALHC056-GFP | Alphabioregen | 1ml frozen Vial | 0.2 EUR |
RFP-Human Lung [SCLC] Adenocarcinoma Cells (H69) |
|||
ALHC057-RFP | Alphabioregen | 1ml frozen Vial | 0.2 EUR |
GFP-Human Lung [SCLC] Adenocarcinoma Cells (H82) |
|||
ALHC058-GFP | Alphabioregen | 1ml frozen Vial | 0.2 EUR |
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 0.2mg/mL |
|||
BNUB3306-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 0.2mg/mL |
|||
BNUB3306-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 0.2mg/mL |
|||
BNUB3308-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 0.2mg/mL |
|||
BNUB3308-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), 0.2mg/mL |
|||
BNUB3309-100 | Biotium | 1uL | 225 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3309), 0.2mg/mL |
|||
BNUB3309-500 | Biotium | 1uL | 485 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3306), 1mg/mL |
|||
BNUM3306-50 | Biotium | 1uL | 396 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |
|||
Napsin A (Lung Adenocarcinoma Marker)(NAPSA/3308), 1mg/mL |
|||
BNUM3308-50 | Biotium | 1uL | 396 EUR |
Description: Primary and secondary antibodies for multiple methodologyimmunostaining detection application |